tykhr
sign in
free sign up
Palvella Therapeutics, Inc
Biotechnology
Healthcare
PVLA
11.05 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
58.98
52 week high
59.73
high
59.60
52 week low
0.00
low
56.56
growth
228.83 %
previous Close
58.71
P/E ratio
market cap
219 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
-9.47 M
-15.71 %
eps
0.00 %
-15.30 %
eps surprise
0.00 %
net profit margin
-947100000.00 %
0.00 %
operating incoming
-9.25 M
-17.52 %
net change in cash
64.19 M
904.73 %
cash on hand
70.43 M
-6.87 %
cost of revenue
0.00 %
top